cholecalciferol and Cardio-Renal-Syndrome

Several studies have shown that cholecalciferol supplementation (25OHD-S) in chronic kidney disease (CKD) improves kidney injury by reducing fibrosis-related vascular calcification and declining apoptosis-linked nephron damage.. Vitamin D deficiency alters in the same manner CMet, CRenal, and others biomarkers in both groups SS; however, these disorders are more acute in blacks compared to whites SS. Oral 25OHD-S a highlighted improvement of eGFR drop, SHPT decrease, decline proteinuria, and cardiac failure risk (NT-proBNP and cTnT) attenuation. Concomitantly, 25OHD-S normalizes

Topics: Biomarkers; Cardio-Renal Syndrome; Cholecalciferol; Dietary Supplements; Humans; Hyperparathyroidism, Secondary; Renal Insufficiency, Chronic; Troponin T; Vitamin D Deficiency